NanoViricides Inc. (NNVC)

[loanranger]

"40% survival and 60% case fatality rate

Exactly what it is in untreated patients

To be fair, the sample size is too small to come to any conclusions but the bloom may be off the rose on that drug!"


He may be right, but does he have to be excited about it? That would be acceptable were he the CEO of a company that could provide a drug that performed better. As it is, it's a little creepy.


BTW, the usual signature area is missing. Does he still think the company is on the NYSE?